Every year, the KU School of Medicine-Wichita holds a Research Forum for students, residents and faculty, as well as anyone interested in community health and medical research, to present and discuss research projects and facilitate research collaboration.
Submit an Abstract
*The deadline to submit is Thursday, March 30.*
Register for the Forum
*The deadline to register is Monday, April 10. Submitting an abstract does NOT register you for the forum.*
Marci Nielsen, Ph.D., MPH
Dr. Nielsen was the Chief Executive Officer of the Patient-Centered Primary Care Collaborative (PCPCC) from 2012-2017, a 501-c-3 membership organization dedicated to advancing an effective and efficient health system built on a strong foundation of primary care and the patient-centered medical home representing over 1,200 diverse health provider, payer, and patient organizations. She held previous positions as: Vice Chancellor for Public Affairs and Associate Professor at the University of Kansas School of Medicine; Executive Director of the Kansas Health Policy Authority (KHPA) -- the single state agency managing Medicaid, the State Children's Health Insurance Program, the State Employee Health Plan, health information technology and health policy; the health lobbyist and assistant director of legislation for the American Federation of Labor and Congress of Industrial Organizations (AFL-CIO); and legislative assistant to U.S. Senator Bob Kerrey (D-Nebraska).
She is on the Board of Directors for the American Board of Family Medicine and the National Academy for State Health Policy, was a committee member for the Institute of Medicine's Leading Health Indicators for Healthy People 2020 and Living Well with Chronic Illness: A Call for Public Health Action. Early in her career she served as a Peace Corps volunteer and in the U.S. Army Reserves. She holds a Ph.D. from Johns Hopkins School of Public Health, an MPH from George Washington University, and a B.S. in biology and psychology from Briar Cliff College.
Richard J. Barohn, M.D.
Dr. Barohn is Chairman of the Department of Neurology and Vice Chancellor for Research at the University of Kansas Medical Center in Kansas City. He is also the Gertrude and Dewey Ziegler Professor of Neurology, and University Distinguished Professor, and the President of the Research Institute.
His present research focuses on myopathies (such as polymyositis and muscular dystrophy), motor neuron disease (such as amyotrophic lateral sclerosis), peripheral neuropathies, and myasthenia gravis. He has developed a number of endpoint scales in neuromuscular disease that have been used in many clinical trials. He has led several multicenter international trials (methotrexate for myasthenia gravis, rasagiline for ALS, memantine for ALS and arimoclomol for IBM). He leads a 40 site comparative effectiveness study of drugs for painful neuropathy funded by PCORI and he is the leader of the rare disease program in the Greater Plains Collaborative PCORnet. He is the Director of Frontiers: The Heartland Institute for Clinical and Translational Research. He has served on the editorial board for Neurology and is the Associate Editor for the Journal of Clinical Neuromuscular Disorders. He was the founding chair of the Section of Neuromuscular Disease in the American Academy of Neurology. Dr. Barohn and his colleagues have also established the Rick's Real Neuromuscular Friends (RRNMF.com) website as a modern method of communication among neuromuscular specialists which is used to discuss cases and serves as a resource for other educational activities.